Ccs Medical Health Service Div is categorized under Services (Unclassified) in Tampa, FL and active since 2011.
Ccs Medical Health Service Div was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Michael A Sicuro at the company’s single location by writing to 625 South Ware Boulevard, Tampa, Florida FL 33619 or by phoning (813) 628-8900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ccs Medical Health Service Div |
Contact Person: | Michael A Sicuro |
Address: | 625 South Ware Boulevard, Tampa, Florida 33619 |
Phone Number: | (813) 628-8900 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Services (Unclassified) |
SIC Code: | 8999 |
NAICS Code: | 6214930 |
Share This Business: |
Ccs Medical Health Service Div was started in 2011 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michael A Sicuro for inquiries that concern Ccs Medical Health Service Div by calling the company number (813) 628-8900, as your correspondence is most welcome. Additionally, the physical location of the single location of Ccs Medical Health Service Div can be found at the coordinates 27.94141,-82.34742 as well as the street address 625 South Ware Boulevard in Tampa, Florida 33619.
For its online presence, you may visit Ccs Medical Health Service Div’s website at and engage with its social media outlets through on Twitter and on Facebook.